Examinando por Autor "Gil-Prieto, Ruth"
Mostrando 1 - 5 de 5
- Resultados por página
- Opciones de ordenación
Ítem Differences in Trends in Admissions and Outcomes among Patients from a Secondary Hospital in Madrid during the COVID-19 Pandemic: A Hospital-Based Epidemiological Analysis (2020–2022)(MDPI, 2023-07-24) Garcia-Carretero, Rafael; Vazquez-Gomez, Oscar; Ordoñez-Garcia, Maria; Garrido-Peño, Noelia; Gil-Prieto, Ruth; Gil-de-Miguel, AngelÍtem Hospitalization burden and epidemiology of the COVID-19 pandemic in Spain (2020-2021)(Springer Science and Business Media LLC, 2023-07-18) Garcia-Carretero, Rafael; Vazquez-Gomez, Oscar; Gil-Prieto, Ruth; Gil-de-Miguel, AngelBackground Spain had some of Europe’s highest incidence and mortality rates for coronavirus disease 2019 (COVID19). Here we describe the epidemiology and trends in hospitalizations, the number of critical patients, and deaths in Spain in 2020 and 2021. Methods We performed a descriptive, retrospective, nationwide study using an administrative database, the Minimum Basic Data Set at Hospitalization, which includes 95–97% of discharge reports for patients hospitalized in Spain in 2020 and 2021. We analyzed the number of hospitalizations, admissions to intensive care units, and deaths and their geographic distribution across regions of Spain. Results As of December 31, 2021, a total of 498,789 patients (1.04% of the entire Spanish population) had needed hospitalization. At least six waves of illness were identified. Men were more prone to hospitalization than women. The median age was 66. A total of 54,340 patients (10.9% of all hospitalizations) had been admitted to the intensive care unit. We identified 71,437 deaths (mortality rate of 14.3% among hospitalized patients). We also observed important differences among regions, with Madrid being the epicenter of hospitalizations and mortality. Conclusions We analyzed Spain’s response to COVID-19 and describe here its experiences during the pandemic in terms of hospitalizations, critical illness, and deaths. This research highlights changes over several months and waves and the importance of factors such as vaccination, the predominant variant of the virus, and public health interventions in the rise and fall of the outbreaks.Ítem Hospitalization Burden Related to Herpes Zoster Infection in Spain (2016–2019)(Springer Science and Business Media LLC, 2022-11-08) Corcuera-Munguia, Marta; Gil-Prieto, Ruth; Garcia-Carretero, Rafael; Gil-de-Miguel, AngelIntroduction: Herpes zoster (HZ) and its complications still represent a significant burden for patients and health care systems. In Spain, vaccination is progressively being introduced and recommended for patients between 65 and 80 years old and patients [ 18 years of age suffering from certain immunosuppression conditions. The aim of this study is to estimate the number of hospital admissions related to HZ from 2016 to 2019 in Spain. Methods: Data were collected from the Minimum Basic DataSet (MBDS) and codified according to the Spanish version of the 10th International Classification of Disease (ICD-10- CM codes B02—B02.9). Among others, variables such as sex, age and presence of complications were included. Results: A total of 27,642 hospitalizations were identified (90% in patients [ 50 and 45.8% in patients [80). Women represented 51.2% of the patients, and 59.9% of patients presented complications related to HZ. The hospitalization rate was 17.74, the mortality rate was 1.2, and the case fatality rate was 6.75%. All rates were significantly higher with age, among men and in complicated HZ. Immunosuppression status for which vaccination had been recommended represented 22.7% of the total cases, affecting mostly individuals [ 65 and causing more deaths in those[ 80 years. The estimated annual cost of hospitalization for herpes zoster was €35,738,285, and the mean cost per patient was €5172. Conclusion: The hospitalization burden for HZ is still important in Spain. Data on the current epidemiology are important to evaluate future vaccination strategies.Ítem Insulin resistance is a cardiovascular risk factor in hypertensive adults without type 2 diabetes mellitus(Springer Science and Business Media LLC, 2023-10-09) Garcia-Carretero, Rafael; Vazquez-Gomez, Oscar; Gil-Prieto, Ruth; Gil-de-Miguel, AngelÍtem The invisible problem of early adolescent pregnancy in the Dominican Republic: a descriptive analysis(Elsevier, 2024-07) González-Rodríguez, Elena; Gil de Miguel, Ángel; Bravo-Infantes, Raúl; Garrido-González, Ignacio; Gil-Prieto, RuthStudy objectives The aim of this article is to describe the problem of pregnancy in girls under 15 years of age in the Dominican Republic in the period 2000–2021, to develop a specific indicator for this age group and describing the related factors. Methods This is an exploratory ecological study, based on secondary data sources, such as birth records from the National Statistics Office (NSO) and the Ministry of Public Health (MPH). We calculated the rates of fertility and pregnancy in early adolescence, as well as analyzed their main determining factors and consequences. Results Fertility Rate in Early Adolescence (FREA) decreases from 6.27 to 1.04 per thousand in the period 2001–2021. The average FREA for 2015–2021 was 1.78. The average Estimated Rate of Pregnancy in Early Adolescence (ERPEA) for the same period was 3.39. Disability-Adjusted Life Years (DALYs) were 11,620 years. Years of Life Lost (YLL) were 9,665.9 years. The prevalence of Low Birth Weight (LBW) in the under 15-year-old age group was 14.2 %. Conclusions Pregnancy in childhood implies risks for both the mother and the child, including low birth weight. The official fertility rate is substantially underreported (2.84 vs. 1.79). The fertility rate indicator traditionally used does not accurately measure the number of pregnancies in women, particularly in specific age groups or populations where pregnancies may be interrupted by various factors. Therefore, the use of ERPEA is recommended. We emphasize the need for implementing the proposed indicator for the target group, as well as monitoring Sustainable Development Goal indicator 3.7.2